Pre-launchFDA pending · Launch Q1 2027
Regulatory

A regulatory strategy built for institutional partners.

We treat regulatory milestones as product milestones. Here's where each track stands today.

FDA 510(k)

In progress

Submitted Q2 2026. Predicate devices cited. Class II classification, moderate risk.

ISO 13485

In progress

Manufacturing QMS certification in audit. Flex facilities (Singapore, Mexico).

HIPAA architecture

Complete

PHI encrypted at rest and in transit. Local-first processing. Granular consent.

SOC 2 Type II

In progress

Security audit underway. Expected completion Q3 2026.

CE Mark

In progress

European MDR application submitted Q3 2026. Notified body engaged.

PMDA (Japan)

Planned

Regulatory strategy in development with local partner.

Plumbing code

In progress

ICC compliance and IAPMO certification for infrastructure components.

Insurance pathway

In progress

CPT code application submitted. CMS coverage strategy in development.